Active — Not RecruitingNot Applicable

STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy

United States1,000 participantsStarted 2020-09-30

Plain-language summary

This research will test the effectiveness of a prenatal provider education and training program designed to facilitate provider adoption of evidence-based practices for the treatment of OUD during pregnancy. Findings from this research will provide high quality evidence about how to increase evidence-based treatment for pregnant women with OUD and subsequent maternal-child health outcomes.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. provides prenatal care (i.e. obstetricians, nurse midwives, advanced practice providers) at obstetric sites,
✓. provides care to pregnant women with OUD
✓. English speaking
✓. meet The Diagnostic and Statistical Manual of Mental Disorders (DSM-V) criteria for OUD
✓. received care at participating sites while pregnant during the study time period and
✓. speak English

What they're measuring

Patient Medication-assisted treatment (MAT) utilization

Timeframe: up to 1 year post delivery

Provider Provision of Buprenorphine

Timeframe: up to 1 year post delivery

Trial details

NCT IDNCT04527926

SponsorUniversity of Pittsburgh

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-04-30

View on ClinicalTrials.gov More Opioid-use Disorder trials